Clinical trial reportAnnals of oncology : official journal of the European Society for Medical OncologyPublished
Nivolumab plus ipilimumab versus sunitinib for first-line treatment of advanced renal cell carcinoma: final analysis of efficacy and safety from the phase III CheckMate 214 trial
Regional connection
Verified An author affiliation on the Europe PMC record names Fox Chase Cancer Center, with Temple Health linked by the institution reference. Affiliation source
- Institutions
- Fox Chase Cancer Center, Temple Health
- County
- Philadelphia County
Publication record
- Type
- Clinical trial report
- Venue
- Annals of oncology : official journal of the European Society for Medical Oncology
- Published
- Topic
- Clinical care
- Subject terms
- Humans; Carcinoma, Renal Cell; Kidney Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Adult; Aged; Aged, 80 and over; Middle Aged; Female; Male; Ipilimumab; Sunitinib
- PubMed ID
- 41786248
- Added to directory
- Source checked